Home > Insider Trading > Filing (0000950170-24-116785)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1750149	Inhibikase Therapeutics Inc.	IKT	Biological Products, (No Disgnostic Substances) (2836)	263407249

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1802453	Roberto Bellini	3350 Riverwood Parkway Se, Suite 1900 Atlanta GA 30339		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-10-21	1,460,000	$1.37	1,460,000	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2024-10-21	60,000	$0.00	60,000	$2.22

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,000		2034-10-21	No	4	A	Direct

Footnotes

These securities are owned directly by BSQUARED CAPITAL INC ("BSQ"). Mr. Bellini is a shareholder and officer of BSQ. Mr. Bellini expressly disclaims beneficial ownership of the securities listed above except to the extent of any pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The option shares vest 50% on each of the first two anniversaries of October 21, 2024.